~~<i id='E8834EC623'><strike id='E8834EC623'><tt id='E8834EC623'><pre id='E8834EC623'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

comprehensive

author：comprehensive 2025-08-12 09:13:39 - browse：2

People taking notes while sitting around a meeting table — Adobe

It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Does Paxlovid work in people vaccinated against Covid

entertainment

hotspot

entertainment

hotspot

leisure time

AdobeMenstruationisacriticalindicatorofhealth.Whetherandwhensomeonewithauterusgetstheirperiod—forthe

WSS

First Opinion Podcast: What happens when kids become caregivers?

Average age of first period drops to 11.9 years, study shows

Stigma and the return of syphilis

Dark money group runs ads on China biotech bill

Adam's Biotech Scorecard: Do Sarepta's exon

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

leisure time

comprehensive

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

Addiction doctors spar with methadone clinics over legislation

In age of alternative facts, a scholarly course on calling out crap

At JPM 2024, hospital systems pitch financial strength to investors

Apple is now the first public company to be valued at $3 trillion

Average age of first period drops to 11.9 years, study shows

Drug repurposing or repositioning? The language matters

Merck to acquire Harpoon Therapeutics for $680 million

Sports medicine is finally prioritizing gender equality

A preacher's new calling: Diversifying neuroscience research

hotspot

A preacher's new calling: Diversifying neuroscience research

Report: NIH

Profiling embryos to choose those with higher IQs is almost a reality

Arena BioWorks launches in Cambridge to speed drug discovery

Prosthetic arm enables patients to feel the objects they grip

Medicare Advantage overpayments discussion gets experts fired up

entertainment

hotspot

hotspot

leisure time